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Abstract
The relative roles of CD4+ and CD8+ T cells in contact hypersensitivity responses have not been fully solved, and remain an
important question. Using an adoptive transfer model, we investigated the role of the respective T cell subset. Magnetic
bead separated CD4+ and CD8+ T cells from oxazolone sensitized C57BL/6 mice were transferred into RAG2/2 mice,
followed by hapten challenge and analysis of inflammatory parameters at 24 hours post exposure. The CD4+ T cell recipient
mice developed partial contact hypersensitivity responses to oxazolone. CD8+ T cells caused significant amplification of the
response in recipients of both CD4+ and CD8+ T cells including ear swelling, type 1 inflammatory mediators, and cell killing.
Unexpectedly, CD8+ T cells were not sufficient to mediate contact hypersensitivity, although abundantly present in the
lymph nodes in the CD8+ T cell reconstituted mice. There were no signs of inflammation at the site of hapten exposure,
indicating impaired recruitment of CD8+ T cells in the absence of CD4+ T cells. These data show that CD4+ T cells mediate
contact hypersensitivity to oxazolone, but CD8+ T cells contribute with the most potent effector mechanisms. Moreover,
our results suggest that CD4+ T cell function is required for the mobilization of CD8+ effector T cells to the site of hapten
exposure. The results shed new light on the relative importance of CD4+ and CD8+ T cells during the effector phase of
contact hypersensitivity.
Citation: Fyhrquist N, Wolff H, Lauerma A, Alenius H (2012) CD8+ T Cell Migration to the Skin Requires CD4+ Help in a Murine Model of Contact
Hypersensitivity. PLoS ONE 7(8): e41038. doi:10.1371/journal.pone.0041038
Editor: Rupert Kaul, University of Toronto, Canada
Received January 21, 2011; Accepted June 20, 2012; Published August 20, 2012
Copyright:  2012 Fyhrquist et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was partly supported by grants from the Academy of Finland (Contracts No 213072 and 214479). The funder had no role in the study design,
data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: nanna.fyhrquist@ttl.fi
Introduction
Contact hypersensitivity (CHS) is a T cell-mediated immune
response to hapten bound to protein carriers in the skin. CHS is
referred to as allergic contact dermatitis (ACD) in the clinic, being
a common inflammatory skin disease in industrialized countries.
ACD is one of the most common occupational diseases, causing a
great socioeconomic burden to the society [1].
CD4+ and CD8+ T cells play distinct roles in the expression of
CHS responses, however, their exact nature and their modes of
action have not been fully resolved, and remain important
questions. CD8+ T cells probably provide the most relevant
effector mechanisms causing tissue damage, while CD4+ T cells
appear multifunctional, involving both effector and regulatory
roles [2,3,4].
Chemical haptens induce inflammation in the skin and secretion
of TNF-alpha and IL-1beta, leading to local vascular activation,
and recruitment of T cells. The activation of antigen-specific T
cells leads to release of IFN-gamma and TNF-alpha, as well as IL-
4 and IL-17, which further stimulate keratinocytes and other local
cells in the skin [4]. This promotes upregulation of adhesion
molecules and chemokines including CXCL9 and CXCL10,
which facilitates the trafficking of T helper 1 (Th1) cells and CD8+
T cells [5].
To study CD4+ and CD8+ effector T cell interaction during the
CHS response, we set up a mouse model of adoptive transfer of
CHS, in which CD4+ and CD8+ T cells were primed in wild type
(WT) mice, isolated and transferred into RAG2/2 recipient
mice, which were challenged by allergen.
Materials and Methods
Animals
C57BL6 and B6.129S7-Rag1tm1Mom/J (RAG2/2) mice (Jack-
son Laboratory) were maintained under pathogen-free conditions.
All animal studies were performed under the approval of the local
animal ethics committee (Approval number ESLH-2008-07152/
Ym-23, Ela¨inkoelautakunta -ELLA, Etela¨-Suomen la¨a¨ninhallitus).
Animal treatment protocol
Female C57BL6 mice were topically treated with oxazolone
(50 ml, 10 mg ml21) on shaved backs. Five days later, CD4+ and
CD8+ T cells were positively selected by magnetic bead separation
(Miltenyi Biotec) from spleens and draining lymph nodes (dLNs),
and intravenously (i.v.) transferred (26106 cells/100 ml PBS/
mouse) into RAG2/2 mice. T cell recipients were challenged
with oxazolone (25 ml, 3 mg ml21) as in Figure 1A to allow for
sufficient expansion of antigen-specific T cells, and ear swelling
was measured and samples were collected at 24 hours after the last
challenge. All experiments were repeated 4 times, with 8 mice per
group. Mice receiving PBS i.v. were included in the study.
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Skin histology
Paraffin-embedded ear tissue sections were stained with H&E,
for counting eosinophils and neutrophils. Frozen ear tissue sections
were stained with anti-CD3+, anti-CD4+, anti-CD8+, and anti-
CD11c+ (BD Pharmingen), PDCA+ (Miltenyi biotec), or anti-F4/
80+ (Acris antibodies) using the immunoperoxidase staining
method. Activated caspase-3 was stained on paraffin-embedded
Figure 1. CD4+ T cells mediate ear swelling responses to oxazolone in the RAG2/2model. (A) The CHS adoptive transfer protocol, (B) ear
swelling in the T cell recipients, and (C) recruitment of eosinophils and neutrophils, (D) F/80+ and CD11c+ cells, and (E) PDCA+ plasmacytoid dendritic
cells to the areas of hapten exposure. (F) Representative immunohistochemical staining of PDCA+ in CD4+ recipients and in mice that received both
subsets of T cells. Bars represent mean +SEM (n = 8 mice/group). *, p,0.05, **, p,0.01; and ***, p,0.001.
doi:10.1371/journal.pone.0041038.g001
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sections using antibody from Cell Signaling Technology, Inc.
Stained cells were counted per HPF at61000 magnification.
Measurements of mRNA expression
RNA was extracted from frozen skin and draining lymph node
(dLN) samples according to TRIzol instructions ((Invitrogen Life
Technologies), followed by reverse transcription and analysis by
Quantitative real-time PCR (TaqMan, AbiPrism 7700 Sequence
Detector System, Applied Biosystems). Primers and target-specific
probes were purchased as pre-developed reagents (Applied
Biosystems). Endogenous 18S rRNA was used to normalize gene
expression between samples.
T cell analyses by flow cytometry
Single cell suspensions prepared from dLN and ear tissue
samples were stained with anti-CD4 Alexa Fluor 780 (Rat IgG2a,
kappa), anti-CD8 Alexa 700 (Rat IgG2a, kappa), anti-CD3 PerCp
(Armenian hamster IgG1, kappa) and anti-OX40 PE (Rat IgG1,
kappa) antibodies (eBioscience), followed by flow cytometric
analysis (BD Pharmingen FACS Canto II).
For IFN-gamma measurements, 16106 cells per well were
incubated with PMA (20 ng/ml) and ionomycine (1000 ng/ml) in
complete RPMI 1640 medium (Invitrogen Life Technologies) for
4 hours, with the addition of brefeldin (10 mg/ml) during the last
hour of incubation, and stained intracellularly with anti-IFN-
gamma (eBioscience).
Statistical analysis
Student’s t-test was used to analyze the data. The data are
expressed as mean values 6 SEM, n= 8. * p,0.05, ** p,0.01;
and *** p,0.001.
Results
CD4+ T cells alone but not CD8+ T cells mediate ear
swelling responses to oxazolone in the RAG2/2 model
To study the roles of CD4+ and CD8+ T cells in CHS, we
injected RAG2/2 mice i.v. with CD4+ or CD8+ T cells from
oxazolone sensitized C57BL donors, followed by topical treatment
of the T cell recipients with oxazolone (Figure 1A). The purities of
the injected T cell subsets were ,98%, and the groups that were
reconstituted with both CD4+ and CD8+ T cells, received them at
a 1:1 ratio (Figure S1).
CD4+ T cells alone induced a significant ear swelling response
to oxazolone at 24 hours post challenge (Figure 1B), and CD4+
and CD8+ T cells acting together induced further swelling of the
ears. Surprisingly, CD8+ T cells alone did not induce notable
swelling of the ears. However, a small addition of CD4+ T cells
(,10%) to the CD8+ T cell injections resulted in a significant
CHS response (Figure S2A). Eosinophils and neutrophils accu-
mulated at the site of hapten exposure in the CD4+ as well as the
CD4+ and CD8+ T cell recipients, but were absent in the CD8+ T
cell recipients (Figure 1C).
T cells influence the recruitment and phenotype of
antigen presenting cells
Hapten exposure leads to modifications of the DC population in
the skin [2]. At 24 hours post challenge, the presence of T cells led
to clearly amplified numbers of F4/80+ macrophages and
Langerhans cells, as well as CD11c+ DCs at the site of hapten
exposure (Figure 1D). Interestingly, the presence of CD8+ T cells
was essential to the recruitment of PDCA+ plasmacytoid DCs
(pDC): pDCs were low in number in all groups of mice, except in
the CD4+ and CD8+ T cell recipients (Figure 1E,F). In the dLNs
the expression of co-stimulatory molecule CD80 at the mRNA
level, but not CD86, was further induced by the presence of any
subtype of T cells (Figure 1G).
CD8+ T cells fail to reach the skin in the absence of CD4+
T cells
After topical hapten exposure hapten specific T cells rapidly
infiltrate the skin. The purity of the injected T cell subsets
remained high (94–98%) throughout the exposure protocol in the
dLNs in the RAG2/2 mice (Figure 2A, upper panels). In
recipients of both subsets, a relatively larger portion of CD4+ T
cells infiltrated the skin compared with the dLNs; CD4/CD8
ratios were generally higher in the skin (Figure 2A, two lower
panels, Figure S2B,C).
Immunohistochemical analyses revealed significant numbers of
CD4+ and CD3+ cells, but no CD8+ cells, in the hapten exposed
areas in the CD4+ T cell recipients (Figure 2B,C). In the mice that
received both CD4+ and CD8+ T cells, CD3+ cell numbers were
further increased, and CD8+ cells were detected. By contrast,
CD3+ and CD8+ cells were lacking in the skin in the CD8+ T cell
recipients, although CD8+ T cells were highly abundant in the
dLNs (Figure S3A,B). No CD3+ cells were detected in the
RAG2/2 mice injected with only PBS (Figure S3C,D). Finally, T
regulatory cell marker Foxp3 was present at the mRNA level in
the skin in the CD4+ T cell recipients, but not in the other groups
of mice (Figure 3F).
CD8+ T cells contribute potently to the expression of
type 1 inflammatory mediators during the CHS response
The CHS response was strong with regards to the local
expression of cytokines IL-1beta, TNF-alpha, IL-17 and IL-4 at
the mRNA level (Figure 3A) in the CD4+ T cell recipients, with no
effects on this part of the response by CD8+ T cells. However, the
expression of type 1 inflammatory mediators IFN-gamma, T-bet,
IL-12 (p35 and p40) (Figure 3B) and IL-27 (EBI3) (Figure 3C), and
multifunctional cytokine TGF-beta (Figure 3D) was significantly
weaker when CD8+ T cells were lacking. CD8+ T cells had no
effect on the expression of IL-10 (Figure 3E).
E-selectin, which is involved in the adhesion of leukocytes to the
endothelium at the site of hapten exposure, was induced locally in
all T cell recipients. Chemokines CCL17, CCL22 and CCL27
which are involved in attracting T-cells specifically to the skin,
were induced only in the groups that received CD4+ T cells, or
CD4+ and CD8+ T cells (Figure 4A,B). CCL27 is recognized by
CCR10+ skin seeking CD4+ T cells [6], and the level of CCR10
mRNA in the dLNs was higher in the CD4+ T cell recipients
compared with the CD8+ T cell recipients (Figure 4C), supporting
previous findings that primarily CD4+ T cells express CCR10.
The expression of CXCL9 and CXCL10, which are instru-
mental to the recruitment of Th1 type cells during the CHS
response, was significantly lower in the CD4+ T cell recipients
which lacked CD8+ T cells (Figure 4D), compared with the group
that received both subsets of T cells. In the CD8+ T cell recipients
that lacked CD4+ T cells, the expression of CXCL9 and CXCL10
stayed at a basal level post challenge, but their receptor CXCR3
was significantly expressed at the mRNA level in the dLNs in the
CD8+ T cell recipients (Figure 4E).
The numbers activated T cells in the dLNs was similar in
all T cells recipients
IFN-gamma is a central effector cytokine in CHS responses,
produced by activated T cells. In the recipients of both CD4+ and
CD4+ and CD8+ T Cells in CHS Responses
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CD8+ T cells, a smaller percentage of CD4+ T cells (Figure 5A)
than CD8+ T cells (Figure 5B) produced IFN-gamma, in line with
previous studies [7]. In the mice that received either CD4+ T cells
or CD8+ T cells, the share of IFN-gamma producing CD4+ (data
not shown) or CD8+ T cells (Figure 5C) was at a similar level.
OX40-OX40 ligand interactions mediate co-stimulatory signals
between activated T cells and DCs [8]. Activation marker OX40
was expressed at similar levels (5–7%) by CD8+ T cells in the
dLNs in the recipients of either CD4+ and CD8+ T cells, or CD8+
T cells only (Figure 5D,E).
Caspase-3 activation in the epidermis
Keratinocyte apoptosis is a main feature of the CHS response,
mediated by cytotoxic activities of mainly CD8+ T cells [2].
Figure 2. CD3+ cells were absent from the skin in the CD8+ T cell recipients. (A) Flow cytometric analyses of CD4+ and CD8+ T cells in dLN
cell suspensions (upper panels) and ear tissue cell supsensions (lower panels). (B) Immunohistochemical staining of CD3+, CD4+ and CD8+ cells in
hapten exposed areas, (C) enumeration of the cells and D) Foxp3 expression at the mRNA level. The types of cell transfers are indicated in the insets in
the figures. Bars represent mean +SEM (n= 8 mice/group). *, p,0.05, **, p,0.01; and ***, p,0.001.
Figure 3. CD8+ T cells amplify Th1 type responses at the site of hapten exposure. Oxazolone induced expression of (A) pro-inflammatory
and type 2 mediators, (B,C) type 1 mediators, and (D) TGF-b, and (E) anti-inflammatory IL-10 at the mRNA level in the hapten exposed areas. Bars
represent mean +SEM (n= 8 mice/group). *, p,0.05, **, p,0.01; and ***, p,0.001.
doi:10.1371/journal.pone.0041038.g003
CD4+ and CD8+ T Cells in CHS Responses
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Caspase-3 is a key mediator of apoptosis, and its activation
requires proteolytic processing of its inactive zymogen into
activated p17 and p12 fragments [9]. By using an antibody that
detects p17, we observed significant activation of caspase-3 in the
epidermal layer of the hapten exposed areas in the recipients of
both subsets of T cells. In contrast, in the mice that received CD4+
T cells only, the level of activated caspase-3 was insignificant
(Figure 6A, B, C).
Discussion
Chemical haptens efficiently activate both CD4+ and CD8+ T
cells, but according to a number of studies, CD8+ T cells usually
dominate the CHS effector response, while CD4+ T cells have a
regulatory role [2,3,4,10,11]. The respective contribution of CD4+
and CD8+ T cells in CHS has been extensively studied using
different strategies, including in vivo depletion of normal mice with
anti-CD4 and anti-CD8 mAbs, transfer of CD4+ or CD8+ T cells
Figure 4. CD8+ T cells amplify the expression of type 1 chemokines. The expression of chemoattractants at the mRNA level: (A) E-selectin,
CCL17, CCL22 and (B) CCL27 expression in ear tissue, and (C) CCR10 expression in LN tissue. (D) CXCL9 and CXCL10 expression in ear tissue and (E)
CXCR3 expression in LN tissue. Bars represent mean +SEM (n= 8 mice/group). *, p,0.05, **, p,0.01; and ***, p,0.001.
doi:10.1371/journal.pone.0041038.g004
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to immune incompetent mice, or the use of transgenic mice. Using
in vivo depletion, Gocinski and Tigelaar [3] were the first to suggest
that CD8+ T cells mediate CHS responses. Subsequent experi-
ments in CD8+ T cell deficient MHC class I knock-out mice
confirmed a strong effector role for CD8+ T cells, and importantly
showed that CD8+ effectors can develop in the absence of CD4+
help [11]. In striking contrast to the established view, our results
suggest that CD4+ T cells play an important effector role during
the CHS response, acting to a certain extent as effector cells
themselves, in addition to guiding CD8+ T cells to the site of
allergen exposure.
CD4+ T cells mediated an attenuated CHS response to
oxazolone in the RAG2/2 model compared with the response
induced by CD4+ and CD8+ T cells together. The presence of
Figure 5. IFN-c is expressed at normal levels in the T cells in the CD8+ T cell recipients. (A) The share of IFN-c expressing (A) CD4+ T cells
and (B) CD8+ T cells in the dLNs in the recipents of CD4+ and CD8+ T cells, and (C) in CD8+ T cells in the recipients of CD8+ T cells. The share of OX40+
CD8+ T cells in (A) recipients of both CD4+ and CD8+ T cells, and in (B) recipients of CD8+ T cells.
doi:10.1371/journal.pone.0041038.g005
Figure 6. CD8+ T cells induce activation of Caspase-3. (A) Enumeration of cells positive for activated caspase-3 and representative
immunohistochemical staining of hapten exposed tissue in (B) CD4+ T cell recipients and in (C) recipients of both T cell subsets.
doi:10.1371/journal.pone.0041038.g006
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CD8+ T cell significantly amplified oedema formation (ie. ear
swelling), the expression of type 1 inflammatory mediators, cell
killing, and the recruitment of PDCA+ cells to the hapten exposed
areas. PDCA+ pDCs are known to accumulate in skin lesions in
allergic contact dermatitis (ACD), and co-localize with natural
killer (NK) cells [12] which they activate through the secretion of
cytokines. Moreover, pDCs affect the function and survival of T
cells, and promote differentiation, maturation and immunostimu-
latory functions of DC [13]. Unexpectedly, CD8+ T cells alone
were not sufficient to mediate CHS responses to oxazolone in the
RAG2/2 mice. Although CD8+ T cells were abundant in the
dLNs in the CD8+ T cell recipients and expressed normal levels of
activation markers (IFN-gamma and OX40), they were not
present in the skin at the site of challenge. However, when
transferred together with CD4+ T cells, CD8+ T cells efficiently
migrated to the skin, and potently amplified the inflammatory
response and induced local cell death. Based on these results, we
suggest that although CD8+ T cells certainly are important
mediators of CHS, they nevertheless require the presence of CD4+
T cells. In previous studies using eg. in vivo depletion of cell subsets
[3] or MHC class I2/2 mice [11], even a minor population of
CD4+ T cells might have played an important role early in the
immune response and helped CD8+ T cells migrate to the skin. In
other disease models, such as viral infection where CD8+ T cells
play an important effector role, CD4+ T cells contribute essentially
to the mobilization of CD8+ T cells to the site of infection through
secretion of IFN-gamma and the induction of local chemokine
secretion in the infected tissue [14]. Similarly, ‘pioneering’ CD4+
T cells are required for the entry of pathogenic T cells in the
central nervous system [15], advocating for an essential role for
CD4+ T cells at the stages after CTL differentiation. Indeed, we
observed minor or no induction at all of local chemokines in the
RAG2/2 mice at the site of hapten exposure when CD4+ T cells
were lacking. Further, CCR10, which together with ligand CCL27
is instrumental in guiding T-cells to skin [6], was expressed at a
low level in the dLNs in the absence of CD4+ T cells. Our findings
will need further studies including comparisons with other contact
sensitizers (eg. TNCB or DNCB) and would benefit from
confirmation in alternative immune incompetent mouse models.
The effects of transferring CD4+ T cells, CD8+ T cells, or CD4+
and CD8+ T cell to the RAG2/2 mice in the CHS model are
summarized in Table S1.
Contact allergens activate DCs through innate immunity
signaling via pattern recognition receptors [16], leading to
amplified expression of inflammatory mediators and molecules
related to antigen presentation and co-stimulation. In addition, T
cells shape the innate immune response through T cell-DC
crosstalk and can alter the expression of MHC molecules and co-
stimulatory molecules [17]. We observed that the presence of T
cells led to the up-regulation of CD80 mRNA, but not CD86 in
the dLNs at 24 hours post challenge.
In conclusion, CD4+ T cells mediated partial CHS responses to
oxazolone in the absence of CD8+ T cells in a RAG2/2 host
environment. Unexpectedly, CD8+ T cells were not sufficient to
mediate CHS responses when transferred alone, although they
were abundantly present in the dLNs in the T cell recipient mice.
Adding CD4+ T cells to CD8+ T cells in the cell transfers resulted
in full scale CHS responses, suggesting on one hand that CD8+ T
cells provide the most relevant effector mechanisms, and on the
other hand that CD4+ T cells are required for the mobilization of
CD8+ T cells to the skin. The results have implications for future
therapeutic approaches, such as targeting specific subsets of T cell
populations.
Supporting Information
Figure S1 Purity and composition of T cell subsets that
were transferred from C57BL6/J into RAG2/2mice: (A)
CD4+ T cells, (B) a 1:1 cocktail of CD4+ and CD8+ T cells, and
(C) CD8+ T cells.
(TIF)
Figure S2 CD4+ T cells guide CD8+ T cells to the site of
allergen exposure. (A) Injecting RAG2/2 mice with 26106 T
cells, at a ratio of 90% CD8+ T cells to 10% CD4+ T cells before
hapten challenge, resulted in significant ear swelling. According to
flow cytometric analyses, CD4/CD8 ratios were relatively lower in
(B) the dLNs compared with (C) the skin.
(TIF)
Figure S3 Abundant CD8+ cells in the dLNs in CD8+ T
cell reconstituted RAG2/2 mice. Immunohistochemical
staining of (A) CD3+ cells and (B) CD8+ cells in the dLNs in
CD8+ T cell recipient RAG2/2 mice. In the RAG2/2 mice
that received PBS only via the tail vein, there were no CD3+ cells
in (C) the dLNs and (D) the hapten exposed ear tissue.
(TIF)
Table S1 Summary of analysed inflammatory parame-
ters in hapten exposed areas in the RAG2/2 mice that
received either CD4+ T cells, CD8+ T cells, or CD4+ and
CD8+ T cells prior to hapten exposure.
(TIF)
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